
Precigen Inc
PGENHealthcare|Biotechnology|USA
$5.33
-0.21 (-3.80%)
Tangible Book
$0.01
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812",
"202912",
"203012"
],
"revenue_estimate": [
124.43,
229.03,
437.53,
620.02,
785.68
],
"ebit_estimate": [
0.11,
101.57,
278.29,
437.26,
581.45
],
"ebitda_estimate": [
-9,
72,
null,
null,
null
],
"net_income_estimate": [
-9.08,
75.14,
278.27,
437.24,
553.75
],
"per_share_eps_estimate": [
-0.03,
0.2,
0.72,
1.14,
1.44
],
"eps_nri_estimate": [
-0.03,
0.2,
0.72,
1.14,
1.44
],
"dividend_estimate": [
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-4.87,
97.57,
278.27,
437.24,
581.43
],
"operating_cash_flow_per_share_estimate": [
-0.05,
0.21,
null,
null,
null
],
"roa_estimate": [
-10.6,
33,
null,
null,
null
],
"roe_estimate": [
-22.1,
38.5,
null,
null,
null
],
"gross_margin_estimate": [
84.2,
86.2,
null,
null,
null
],
"operating_cash_flow_estimate": [
-17.72,
74.4,
null,
null,
null
],
"pettm_estimate": [
0,
26.63,
7.4,
4.67,
3.7
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "233.41",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 233.41,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
27.84,
33.46,
39.63,
52.9,
60.8,
71.7,
82.8
],
"ebit_estimate": [
-3.75,
1.44,
8.41,
null,
null,
null,
null
],
"ebitda_estimate": [
-4,
-1,
2,
null,
null,
null,
null
],
"net_income_estimate": [
-4.75,
0.94,
7.41,
null,
null,
null,
null
],
"per_share_eps_estimate": [
-0.01,
0,
0.01,
0.05,
0.07,
0.1,
0.12
],
"eps_nri_estimate": [
-0.01,
0,
0.01,
0.05,
0.07,
0.1,
0.12
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-4.75,
0.94,
7.41,
null,
null,
null,
null
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
113.3,
40.96,
22.85,
15.66,
null,
null,
null
],
"long_term_growth_rate_mean": 0,
"long_term_revenue_growth_rate_mean": "233.41",
"future_per_share_eps_estimate_growth": null,
"future_eps_nri_estimate_growth": null,
"future_revenue_estimate_growth": 233.41,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": null,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}